Systematic review maps cellular senescence regulatory network and emerging theranostic approaches
This systematic review examines the molecular mechanisms orchestrating cellular senescence, including the p53/p21 and p16/RB pathways, mitochondrial stress, and SASP programs, and how these are altered across cancer, metabolic, skeletal, and degenerative diseases. The authors discuss emerging theranostic strategies combining detection and intervention—such as enzyme-activatable prodrugs targeting senescence markers, smart nanocarriers, and engineered immune cells—alongside new methods for quantifying senescent burden in vivo.
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 15, 2026 · Discovered: Sep 15, 2026 · Assessed: — · Research update
What it does not prove
- Limitations have not yet been verified. Read the primary source.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Systematic review
- Sample size
- —
- Duration
- —
- Population
- —
- Primary outcome
- —
- Effect size
- —
- Significance
- Not reported
- Journal
- ACS Biomaterials Science & Engineering
- Published
- Sep 15, 2026
Sources
Primary source
- ACS biomaterials science & engineering ↗Peer reviewed
Assessment history
9/23/2026 · SUPERSEDED: Source updated; assessment withdrawn pending review.
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
No comments yet
Be the first to weigh in on this evidence.